Circulation, Vol 90, 17-22, Copyright © 1994 by American Heart Association
C Indolfi, A Maione, M Volpe, A Rapacciuolo, G Esposito, R Ceravolo, V Rendina, M Condorelli and M Chiariello
BACKGROUND: The alpha-adrenergic component of the sympathetic nervous
system plays a major role in the pathophysiology, clinical manifestations,
and natural history of human congestive heart failure (CHF). However, the
functional integrity of vascular alpha 1- and alpha 2-adrenoceptors in CHF
remains to be elucidated. The present study was designed to assess the
vascular responsiveness of alpha 1- and alpha 2- adrenoceptors in patients
with CHF. METHODS AND RESULTS: To evaluate alpha 1- and alpha
2-adrenoceptor responsiveness, we studied the effects of the regional
infusion into the brachial artery of increasing doses of phenylephrine (a
selective alpha 1-adrenoceptor agonist) and BHT 933 (a selective alpha
2-adrenoceptor agonist) on vascular responses in 12 healthy subjects and in
24 patients with CHF secondary to primary dilated cardiomyopathy or
ischemic heart disease. Left ventricular ejection fraction was measured by
radionuclide angiography, and forearm blood flow was determined by venous
occlusion plethysmography. Phenylephrine reduced forearm blood flow in
normal subjects from 5.2 +/- 0.9 to 2.5 +/- 0.6 mL per 100 mL of tissue/min
(P < .05) at the highest dose (-50.8 +/- 4.8% versus baseline). A
similar vasoconstriction was obtained in patients with CHF (from 3.5 +/-
0.5 to 1.5 +/- 0.2 mL per 100 mL of tissue/min (P < .05) (-58.7 +/- 5.0%
versus baseline). The dose-response curves produced by phenylephrine in the
two groups were comparable. The highest dose of BHT 933 reduced forearm
blood flow in normal subjects from 5.3 +/- 0.9 to 2.3 +/- 0.6 mL per 100 mL
of tissue/min (P < .05) (-59.0 +/- 4.9% versus baseline). In patients
with CHF, a similar vasoconstriction was obtained (from 4.2 +/- 0.8 to 1.5
+/- 0.3 mL per 100 mL of tissue/min, P < .05, -62.1 +/- 6.5% versus
baseline). The dose-response curves produced by BHT 933 also were
comparable in the two groups. In patients with CHF, plasma concentrations
of norepinephrine were significantly higher than in normal subjects.
CONCLUSIONS: The results of the present study demonstrate that alpha 1- and
alpha 2-adrenoceptor stimulations produced an equivalent vasoconstriction
in patients with CHF and in normal subjects. This indicates that the
vascular responsiveness to alpha-adrenoceptor agonists may be preserved in
the limb vessels of patients with CHF.
ARTICLES
Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure
Department of Medicine, University Federico II, Naples, Italy.
This article has been cited by other articles:
![]() |
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Makita, M. Nakamura, A. Ohira, S. Ito, K. Yoshioka, A. Hirose, T. Nakajima, K. Komoda, K. Kawazoe, and K. Hiramori Impaired Peripheral Vasodilation in Ischemic and Nonischemic Limbs of Patients with Unilateral Arteriosclerosis Obliterans: Effect of Revascularization on Leg Hemodynamics Vascular and Endovascular Surgery, September 1, 1998; 32(5): 491 - 502. [Abstract] [PDF] |
||||
![]() |
F. Perticone, R. Ceravolo, R. Maio, G. Ventura, A. Zingone, N. Perrotti, and P. L. Mattioli Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Endothelium-Dependent Vasodilation in Never Treated Hypertensive Patients Hypertension, April 1, 1998; 31(4): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Indolfi, F. Piscione, R. Ceravolo, A. Maione, A. Focaccio, M. A. Rao, G. Esposito, M. Condorelli, and M. Chiariello Limb Vasoconstriction After Successful Angioplasty of the Left Anterior Descending Coronary Artery Circulation, October 15, 1995; 92(8): 2109 - 2112. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |